Siregar Adiatma Y M, Komarudin Dindin, Leuwol Barnabas, Afriandi Irvan, Djuhaeni Heni, Baltussen Rob
Department of Economic and Development Studies, Faculty of Economics, Padjadjaran University. Jl. Pasirkaliki no. 190, Bandung 40151, Indonesia.
Acta Med Indones. 2009 Jul;41 Suppl 1:70-4.
The HIV epidemic in Indonesia is among the fastest growing in Asia, and limited funding is available for HIV/AIDS control. This raises a number of important policy questions, about the adequacy of the level of available funding, the appropriateness of its use, and its financial sustainability. This paper puts these questions in context of the present Indonesian health system. The Indonesian health policy response to HIV/AIDS faces a number of challenges. The nature of the Indonesian HIV epidemic (increasing overall prevalence, with different epidemic profiles); the characteristics of the Indonesian health system (decentralized policy making, low and inequitable funding), and the low and highly internationalized funding of HIV/AIDS control (resulting in low service coverage and questions of sustainability) draw out a very specific health environment of HIV/AIDS. Economic analyses in health are instrumental to guide policy makers on the best use of scarce resources, and holds as such also large potential in this context. However, very little information on the costs and effects of HIV/AIDS control in Indonesia is available, and we call for a broader application.
印度尼西亚的艾滋病疫情是亚洲增长最快的之一，且用于艾滋病防治的资金有限。这引发了一些重要的政策问题，涉及可用资金水平是否充足、资金使用是否恰当以及其财务可持续性。本文将这些问题置于当前印度尼西亚卫生系统的背景下进行探讨。印度尼西亚针对艾滋病的卫生政策应对面临诸多挑战。印度尼西亚艾滋病疫情的特点（总体患病率上升，且疫情情况各异）、印度尼西亚卫生系统的特征（政策制定分散、资金不足且分配不均）以及艾滋病防治资金水平低且高度依赖国际资金（导致服务覆盖范围有限以及可持续性问题）构成了艾滋病防治非常特殊的卫生环境。卫生领域的经济分析有助于指导政策制定者最佳利用稀缺资源，在此背景下也具有很大潜力。然而，关于印度尼西亚艾滋病防治成本和效果的信息非常少，我们呼吁更广泛地应用此类分析。
